LHC Group
Market Cap
US$4.1b
Last Updated
2019/11/20 23:54 UTC
Data Sources
Company Financials +
Executive Summary
LHC Group, Inc., a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States.
Snowflake
Fundamentals
Flawless balance sheet with proven track record.
Similar Companies
Share Price & News
How has LHC Group's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: LHCG has not had significant price volatility in the past 3 months.
Market Performance
7 Day Return
2.4%
LHCG
5.3%
US Healthcare
0.5%
US Market
1 Year Return
37.7%
LHCG
4.4%
US Healthcare
16.1%
US Market
Return vs Industry: LHCG exceeded the US Healthcare industry which returned 4.4% over the past year.
Return vs Market: LHCG exceeded the US Market which returned 16.1% over the past year.
Shareholder returns
| LHCG | Industry | Market | |
|---|---|---|---|
| 7 Day | 2.4% | 5.3% | 0.5% |
| 30 Day | 14.0% | 12.3% | 3.9% |
| 90 Day | 8.7% | 15.7% | 6.6% |
| 1 Year | 37.7%37.7% | 6.2%4.4% | 18.7%16.1% |
| 3 Year | 200.3%200.3% | 51.9%45.1% | 47.2%37.7% |
| 5 Year | 445.5%445.5% | 69.6%58.0% | 61.5%43.7% |
Price Volatility Vs. Market
How volatile is LHC Group's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 day ago | Simply Wall St
Is LHC Group (NASDAQ:LHCG) A Risky Investment?1 week ago | Simply Wall St
LHC Group, Inc. Just Missed Earnings And Its EPS Looked Sad - But Analysts Have Updated Their Models2 weeks ago | Simply Wall St
Announcing: LHC Group (NASDAQ:LHCG) Stock Soared An Exciting 422% In The Last Five YearsValuation
Is LHC Group undervalued compared to its fair value and its price relative to the market?
28.1%
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: LHCG ($130.71) is trading below our estimate of fair value ($181.83)
Significantly Below Fair Value: LHCG is trading below fair value, but not by a significant amount.
Price To Earnings Ratio
PE vs Industry: LHCG is poor value based on its PE Ratio (42.7x) compared to the Healthcare industry average (21.5x).
PE vs Market: LHCG is poor value based on its PE Ratio (42.7x) compared to the US market (18x).
Price to Earnings Growth Ratio
PEG Ratio: LHCG is poor value based on its PEG Ratio (1.6x)
Price to Book Ratio
PB vs Industry: LHCG is overvalued based on its PB Ratio (2.9x) compared to the US Healthcare industry average (2.6x).
Next Steps
Future Growth
How is LHC Group forecast to perform in the next 1 to 3 years based on estimates from 12 analysts?
26.6%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: LHCG's forecast earnings growth (26.6% per year) is above the savings rate (2.7%).
Earnings vs Market: LHCG's earnings (26.6% per year) are forecast to grow faster than the US market (14.3% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: LHCG's revenue (7.4% per year) is forecast to grow faster than the US market (7.3% per year).
High Growth Revenue: LHCG's revenue (7.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: LHCG's Return on Equity is forecast to be low in 3 years time (11%).
Next Steps
Past Performance
How has LHC Group performed over the past 5 years?
27.5%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: LHCG has large one-off items impacting its financial results.
Growing Profit Margin: LHCG's current net profit margins (4.6%) are higher than last year (3.9%).
Past Earnings Growth Analysis
Earnings Trend: LHCG's earnings have grown significantly by 27.5% per year over the past 5 years.
Accelerating Growth: LHCG's earnings growth over the past year (53.7%) exceeds its 5-year average (27.5% per year).
Earnings vs Industry: LHCG earnings growth over the past year (53.7%) exceeded the Healthcare industry 9.7%.
Return on Equity
High ROE: LHCG's Return on Equity (7.6%) is considered low.
Return on Assets
Return on Capital Employed
Next Steps
Financial Health
How is LHC Group's financial position?
Financial Position Analysis
Short Term Liabilities: LHCG's short term assets ($373.0M) exceeds its short term liabilities ($244.4M)
Long Term Liabilities: LHCG's short term assets ($373.0M) exceeds its long term liabilities (355.9M)
Debt to Equity History and Analysis
Debt Level: LHCG's debt to equity ratio (15.5%) is considered satisfactory.
Reducing Debt: LHCG's debt to equity ratio has reduced from 20% to 15.5% over the past 5 years.
Debt Coverage: LHCG's debt is well covered by operating cash flow (54.8%).
Interest Coverage: LHCG's interest payments on its debt are well covered by EBIT (19.2x coverage).
Balance Sheet
Inventory Level: LHCG has a low level of unsold assets or inventory.
Debt Coverage by Assets: LHCG's debt is covered by short term assets (assets are 1.6x debt).
Next Steps
Dividend
What is LHC Group's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Current dividend yield vs market & industry
Notable Dividend: Unable to evaluate LHCG's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.
High Dividend: Unable to evaluate LHCG's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if LHCG's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if LHCG's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of LHCG's dividend in 3 years as they are not forecast to pay a notable one for the US market.
Next Steps
Management
What is the CEO of LHC Group's salary, the management and board of directors tenure and is there insider trading?
3.6yrs
Average management tenure
CEO
Keith Myers (60yo)
25.8yrs
Tenure
US$4,492,614
Compensation
Mr. Keith G. Myers has been the Co-Founder, Chairman and Chief Executive Officer of LHC Group, Inc. since 1994. Mr. Myers has been Director of Almost Family, Inc. since April 1, 2018. He served as the Pres ...
CEO Compensation Analysis
Compensation vs Market: Keith's total compensation ($USD4.49M) is about average for companies of similar size in the US market ($USD5.09M).
Compensation vs Earnings: Keith's compensation has increased by more than 20% in the past year.
Management Age and Tenure
3.6yrs
Average Tenure
51yo
Average Age
Experienced Management: LHCG's management team is considered experienced (3.6 years average tenure).
Board Age and Tenure
9.0yrs
Average Tenure
61.5yo
Average Age
Experienced Board: LHCG's board of directors are considered experienced (9 years average tenure).
Insider Trading
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
| Entity | Individual |
| Role | President President & COO |
| Shares | 3,306 |
| Max Price | US$115.87 |
| Entity | Individual |
| Role | Member of the Board of Directors Consultant & Director |
| Shares | 30,515 |
| Max Price | US$113.76 |
| Entity | Individual |
| Role | Member of the Board of Directors Independent Director |
| Shares | 12,000 |
| Max Price | US$117.20 |
| Entity | Individual |
| Role | President President & COO |
| Shares | 448 |
| Max Price | US$120.00 |
| Entity | Individual |
| Role | President President & COO |
| Shares | 15,151 |
| Max Price | US$107.06 |
| Entity | Individual |
| Role | Chief Financial Officer CFO & Treasurer |
| Shares | 11,003 |
| Max Price | US$107.36 |
| Entity | Individual |
| Role | Member of Advisory Board Transitional Advisory Council |
| Shares | 3,000 |
| Max Price | US$102.09 |
| Entity | Individual |
| Shares | 5,239 |
| Max Price | US$105.26 |
Ownership Breakdown
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 27.5%.
Management Team
Keith Myers (60yo)
Co-Founder
- Tenure: 25.8yrs
- Compensation: US$4.49m
Johnny Indest (67yo)
Consultant & Director
- Tenure: 19.4yrs
- Compensation: US$205.27k
Don Stelly (50yo)
President & COO
- Tenure: 9yrs
- Compensation: US$3.59m
Josh Proffitt (41yo)
CFO & Treasurer
- Tenure: 3.6yrs
- Compensation: US$3.26m
JoAnne Little
Senior VP & Chief Compliance Officer
- Tenure: 6.8yrs
John Thompson
Senior VP & Chief Information Officer
- Tenure: 3.6yrs
Marcus Macip
Executive VP & Chief Administrative Officer
- Tenure: 0yrs
Bruce Greenstein (51yo)
Executive VP and Chief Strategy & Innovation Officer
- Tenure: 1.2yrs
- Compensation: US$1.54m
Nicholas Gachassin (52yo)
Executive VP & General Counsel
- Tenure: 0.8yrs
Collin McQuiddy (42yo)
SVP & Chief Accounting Officer
- Tenure: 0.3yrs
Board Members
Ron Nixon (63yo)
Independent Director
- Tenure: 18.3yrs
- Compensation: US$201.65k
Cliff Holtz (59yo)
Independent Director
- Tenure: 2yrs
- Compensation: US$284.29k
Jonathan Goldberg (68yo)
Independent Director
- Tenure: 2yrs
- Compensation: US$284.29k
Ty Wilburn (66yo)
Transitional Advisory Council
- Tenure: 0.7yrs
- Compensation: US$287.29k
William Turner (53yo)
Independent Director
- Tenure: 5.3yrs
- Compensation: US$204.65k
Keith Myers (60yo)
Co-Founder
- Tenure: 25.8yrs
- Compensation: US$4.49m
Johnny Indest (67yo)
Consultant & Director
- Tenure: 19.4yrs
- Compensation: US$205.27k
Billy Tauzin (75yo)
Lead Independent Director
- Tenure: 14.8yrs
- Compensation: US$216.65k
Monica Azare (52yo)
Independent Director
- Tenure: 12yrs
- Compensation: US$192.65k
Jake Delhomme (44yo)
Member of Founder's Advisory Board
- Tenure: 5.9yrs
Company Information
LHC Group, Inc.'s company bio, employee growth, exchange listings and data sources
Key Information
- Name: LHC Group, Inc.
- Ticker: LHCG
- Exchange: NasdaqGS
- Founded: 1994
- Industry: Health Care Services
- Sector: Healthcare
- Market Cap: US$4.119b
- Shares outstanding: 31.51m
- Website: https://www.lhcgroup.com
Number of Employees
Location
- LHC Group, Inc.
- 901 Hugh Wallis Road South
- Lafayette
- Louisiana
- 70508
- United States
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| LH6 | DB (Deutsche Boerse AG) | Yes | Common Stock | DE | EUR | Jun 2005 |
| LHCG | NasdaqGS (Nasdaq Global Select) | Yes | Common Stock | US | USD | Jun 2005 |
Biography
LHC Group, Inc., a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States. The company’s Home Health Services segment offers home nu ...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2019/11/20 23:54 |
| End of Day Share Price | 2019/11/20 00:00 |
| Earnings | 2019/09/30 |
| Annual Earnings | 2018/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.